THESIS PHARMACY
LIVE

Serial Number

99378019

Owner

Thesis Pharma Ventures

Attorney

Suzann Moskowitz

Filing Date

Sep 5, 2025

Add to watchlist:

No watchlists yet
View on USPTO

THESIS PHARMACY Trademark

Serial Number: 99378019

THESIS PHARMACY is a trademark filed by Thesis Pharma Ventures on September 5, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Thesis Pharma Ventures (2 trademarks)

3033 W Parker Rd
Plano, TX 75023

Entity Type: 16

Trademark Details

Filing Date

September 5, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of injuries, pain, wellness conditions, men's health conditions, women's health conditions, immunological conditions, sexual dysfunction, cosmetology conditions, ENT conditions, scars, hair loss, hormone fluctuation, eye disorders, dental conditions, weight management, aging-related concerns, and dermatological conditions of humans; Pharmaceutical preparations for the treatment of veterinary issues

Pharmaceutical compounding services

Custom manufacture of pharmaceuticals; Custom manufacture of prescription drugs and pharmaceuticals; Custom compounding of prescription drugs and pharmaceuticals on a per-prescription basis; contract manufacturing services in the nature of large-scale manufacture of pharmaceutical preparations, prescription drugs, and sterile and non-sterile pharmaceutical products

Retail pharmacy services; Mail order pharmacy services; Retail store services featuring prescription pharmaceuticals; On-line retail store services featuring prescription pharmaceuticals

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 6, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 6, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 6, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 9, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 9, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 23, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 23, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 21, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2025 NWOS
NEW APPLICATION ENTERED
Sep 5, 2025 NWAP